CLGN
CollPlant Biotechnologies Ltd.
NASDAQ · Healthcare · Biotechnology · IL
$4.56
+9.62%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- 3.86x
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 1.76x
- Price / sales
- 22.16x
- Price / cash flow
- -0.74x
Enterprise value
- Enterprise value
- $7.0M
- EV / sales
- 18.02x
- EV / EBITDA
- -0.58x
- EV / EBIT
- -0.54x
- Market cap
- $8.6M
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Mar 1, 2026